MAPT and Cognitive impairment: Next, we tested whether in aged WT mice showing an increased tau deposition in the brain [62] and exposed to TBI as a second neurodegenerative hit [28], Aβ1-6A2V(D) treatment was also effective in attenuating cognitive impairment.